坏死性外耳道炎继发颈椎骨髓炎1例并文献复习

doi:10.6040/j.issn.1673-3770.0.2022.174

摘要/Abstract

摘要： 目的探讨坏死性外耳道炎继发颈椎骨髓炎的诊疗方法及临床特点。方法回顾性分析1例糖尿病老年患者坏死性外耳道炎合并C2-C6颈椎椎体骨髓炎的病历资料并检索文献,总结其临床表现、诊断、治疗方法及预后。结果检索获得2005~2022年国内外发表的5篇文献, 加上本例患者共纳入4个病例,其中男3例、女1例,54~72岁,除1例有头颈部放疗史外其余3例均合并糖尿病,病变范围均广泛,累及2~5个颈椎椎体,病原体为不同细菌,经过系统治疗后,3例(75%)死亡,与细菌耐药、患者依从性差及全身健康状况差可能有关。结论坏死性外耳道炎病变可从颅底骨髓炎进一步扩展至颈椎骨髓炎危及生命,需要积极治疗。

关键词: 坏死性外耳道炎, 骨髓炎, 糖尿病, 颈椎

Abstract: Objective To outline and analyze the clinical features and treatment option of cervical osteomyelitis secondary to necrotizing otitis externa. Methods We performed a retrospective review, along with literature review, of a case of C2-C6 osteomyelitis secondary to a necrotizing otitis externa in a diabetic patient, in order to outline its clinical manifestation, diagnosis, treatment option and prognosis. Results A total of five relevant studies published in Chinese and English from 2005 to 2022 were reviewed, and four cases(including the case presented in this study)were analyzed. The four cases involved three men and one woman(age range: 54-72 years). Only one patient had a history of head and neck radiotherapy, the remaining three were known diabetic patients. The lesions were extensive, involving two to five vertebral bodies. The causative pathogens isolated were all bacteria; however, the strains varied among the cases. After a systematic treatment, three patients(75%)succumbed to the disease as a result of bacterial resistance, poor compliance to medications, and severe comorbidity. Conclusion The lesions of necrotizing otitis externa can extend from the skull base to the cervical vertebrae, causing cervical osteomyelitis: a life-threatening condition that requires an aggressive treatment.

Key words: Necrotizing otitis externa, Osteomyelitis, Diabetes, Cervical vertebrae

中图分类号:

R764.1+1

田俊, 刘良发, 白佳麒. 坏死性外耳道炎继发颈椎骨髓炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 1-5.

TIAN Jun, LIU Liangfa, BAI Jiaqi. Cervical vertebral osteomyelitis secondary to necrotizing otitis externa:a case report and review of literature[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 1-5.

参考文献

[1] 江远明, 马志跃, 肖红俊. 坏死性外耳道炎[J]. 临床耳鼻咽喉头颈外科杂志, 2007, 21(4): 185-187. doi:10.3969/j.issn.1001-1781.2007.04.020.
[2] Treviño González JL, Reyes Suárez LL, Hernández de León JE. Malignant otitis externa: an updated review[J]. Am J Otolaryngol, 2021, 42(2): 102894. doi:10.1016/j.amjoto.2020.102894.
[3] Marina S, Goutham MK, Rajeshwary A, et al. A retrospective review of 14 cases of malignant otitis externa[J]. J Otol, 2019, 14(2): 63-66. doi:10.1016/j.joto.2019.01.003.
[4] Chandler JR. Malignant external otitis[J]. Laryngoscope, 1968, 78(8): 1257-1294. doi:10.1288/00005537-196808000-00002.
[5] Glikson E, Sagiv D, Wolf M, et al. Necrotizing otitis externa: diagnosis, treatment, and outcome in a case series[J]. Diagn Microbiol Infect Dis, 2017, 87(1): 74-78. doi:10.1016/j.diagmicrobio.2016.10.017.
[6] 屠冠军, 金明熙, 朱悦, 等. 脊柱化脓性骨髓炎的诊断及治疗[J]. 中华骨科杂志, 2004, 24(6): 355-358. doi:10.3760/j.issn: 0253-2352.2004.06.009. TU Guanjun, JIN Mingxi, ZHU Yue, et al. Diagnosis and treatment of pyogenic spinal osteomyelitis[J]. Chinese Journal of Orthopaedics, 2004, 24(6): 355-358. doi:10.3760/j.issn: 0253-2352.2004.06.009.
[7] Low G, Leong A, George R, et al. C1/C2 osteomyelitis secondary to malignant otitis externa complicated by atlantoaxial subluxation-a case report and review of the literature[J]. AME Case Rep, 2020, 4: 19. doi:10.21037/acr.2020.03.04.
[8] 黄冠又, 曹楚南, 甘鸿川. 颅底骨髓炎的研究进展[J]. 国际神经病学神经外科学杂志, 2015, 42(1): 66-69. doi:10.16636/j.cnki.jinn.2015.01.012.
[9] Prasad KC, Prasad SC, Mouli N, et al. Osteomyelitis in the head and neck[J]. Acta Otolaryngol, 2007, 127(2): 194-205. doi:10.1080/00016480600818054.
[10] Singh A, Al Khabori M, Hyder MJ. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation[J]. Otolaryngol Head Neck Surg, 2005, 133(1): 121-125. doi:10.1016/j.otohns.2005.03.024.
[11] Bruschini L, Berrettini S, Christina C, et al. Extensive skull base osteomyelitis secondary to malignant otitis externa[J]. J Int Adv Otol, 2019, 15(3): 463-465. doi:10.5152/iao.2019.5406.
[12] Arsovic N, Radivojevic N, Jesic S, et al. Malignant otitis externa: causes for various treatment responses[J]. J Int Adv Otol, 2020, 16(1): 98-103. doi:10.5152/iao.2020.7709.
[13] Meltzer PE, Kelemen G. Pyocyaneous osteomyelitis of the temporal bone, mandible and zygoma.[J]. Laryngoscope,1959,169:1300-1316.doi:10.1288/00005537-195910000-00006.
[14] Nadol JB Jr. Histopathology of Pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis[J]. Am J Otolaryngol, 1980, 1(5): 359-371. doi:10.1016/s0196-0709(80)80016-0.
[15] Peled C, El-Seid S, Bahat-Dinur A, et al. Necrotizing otitis externa-analysis of 83 cases: clinical findings and course of disease[J]. Otol Neurotol, 2019, 40(1): 56-62. doi:10.1097/MAO.0000000000001986.
[16] Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 infectious diseases society of America(IDSA)clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults[J]. Clin Infect Dis, 2015, 61(6): e26-e46. doi:10.1093/cid/civ482.
[17] Bernard L, Dinh A, Ghout I, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial[J]. Lancet, 2015, 385(9971): 875-882. doi:10.1016/S0140-6736(14)61233-2.
[18] Sturm JJ, Stern Shavit S, Lalwani AK. What is the best test for diagnosis and monitoring treatment response in malignant otitis externa? [J]. Laryngoscope, 2020, 130(11): 2516-2517. doi:10.1002/lary.28609.
[19] Sokoowski J, Lachowska M, Karchier E, et al. Skull base osteomyelitis: factors implicating clinical outcome[J]. Acta Neurol Belg, 2019, 119(3): 431-437. doi:10.1007/s13760-019-01110-w.
[20] Ju KL, Kim SD, Melikian R, et al. Predicting patients with concurrent noncontiguous spinal epidural abscess lesions[J]. Spine J, 2015, 15(1): 95-101. doi:10.1016/j.spinee.2014.06.008.

相关文章 15

[1]	王娇娇,李苗综述宋宗明审校. 糖尿病视网膜病变的机制和细胞模型研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 93-99.
[2]	王娟,宋英鸾,耿江桥,温鑫,史雅楠. 婴幼儿急性上颌骨骨髓炎合并鼻中隔脓肿1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 91-96.
[3]	王惠, 王俊,孙乙,于腾飞,朱玉广, 朱艳. 玻璃体腔注射HGF-MSCs对糖尿病大鼠视网膜HGF表达的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 72-77.
[4]	黄天泽,陈迪综述李莹审校. 机器学习在眼表疾病诊断及角膜手术中的应用进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 13-19.
[5]	高朗, 陈红梅,白晔,秦雪娇. 手术时长与内眼手术围手术期血糖波动的相关分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 70-75.
[6]	蒲雅迪,李元彬. 肺炎克雷伯杆菌性肝脓肿眼内炎31例[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 95-98.
[7]	刘志高,王淑雅,韩旭光,王玉,李志伟,马爱华,赵博军. 增殖性糖尿病视网膜病变术前玻璃体腔应用阿柏西普的时机及其疗效观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 99-103.
[8]	刘建波,张环. 超声乳化联合玻璃体腔药物注射治疗白内障合并糖尿病性黄斑水肿[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 99-104.
[9]	李宝华,刘平,王新. β-榄香烯影响糖尿病大鼠视网膜中IL-1β、ICAM-1表达分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 111-114.
[10]	王新娟,沙士珂,马路生. 糖尿病视网膜病变术后黑矇一例报告[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 171-172.
[11]	刘万智,陈珺,樊长春. 康柏西普治疗增生性糖尿病视网膜病变[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 88-91.
[12]	张颖,陈红梅,吴欣怡. 糖尿病大鼠角膜上皮创伤愈合中IGF-1的表达[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 74-78.
[13]	周学义,李一鸣,王美菊,张苑苑,张历浊. 25+微创玻璃体视网膜手术联合玻璃体腔注射雷珠单抗治疗增生型糖尿病视网膜病变的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 87-89.
[14]	周玮琰,王洪亚,杜秀娟,董卫红. 甘糖酯对糖尿病大鼠视网膜病变中血管生成因子VEGF表达的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 90-95.
[15]	靳琳,潘庆敏,胡磊. 玻璃体腔注射雷珠单抗治疗CSME及NCSME的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 96-98.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed